FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015296710> ?p ?o ?g. }

• W2015296710 abstract "Opioid-induced constipation (OIC) is one of the major symptoms in palliative care with a prevalence of 30-50%. Methylnaltrexone for the treatment of OIC is significantly more effective than placebo, but only in about fifty percent of the patients regardless of dose increase. Dose increases cause increased toxicity without additional efficacy, and are therefore not recommended. While methylnaltrexone is a μ-receptor antagonist, only a few opioids are solely μ-receptor agonists. Therefore, the response to methylnaltrexone may be determined by the receptor-profile of a specific opioid. In addition, methylnaltrexone may also affect the immune system and angiogenesis as was found in pre-clinical studies. Primary aim of this study is to determine differences in the efficacy of methylnaltrexone prescribed to resolve opioid induced constipation between three commonly used opioid subtypes: morphine sulphate, oxycodone and fentanyl. Secondary aim is to explore potential immunomodulatory and antiangiogenic effects of methylnaltrexone. In this multi-center, prospective, parallel group trial we will evaluate the efficacy of methylnaltrexone in resolving OIC occurring as a side effect of the most common opioid subtypes: morphine, oxycodone and fentanyl. In total 195 patients with OIC despite prophylactic laxatives will receive methylnaltrexone every other day up to fourteen days. Patients will report its effect in a laxation diary. Group allocation is based on the opioid type the patient is using. At the start and end of the study period patients complete the Bowel Function Index questionnaire. A subgroup of the patients will donate blood for analysis of immunomodulatory- and anti-angiogenic effects of methylnaltrexone. In this study we aim to determine the efficacy of methylnaltrexone per opioid subtype to reduce constipation. We expect that the outcome of this study will improve the clinical use of methylnaltraxone. This trial is registered at clinicaltrials.gov: NCT01955213 and in the Dutch trial register: NTR4272 ." @default.
• W2015296710 created "2016-06-24" @default.
• W2015296710 creator A5010842306 @default.
• W2015296710 creator A5013858600 @default.
• W2015296710 creator A5018795520 @default.
• W2015296710 creator A5020320519 @default.
• W2015296710 creator A5030542961 @default.
• W2015296710 creator A5040190541 @default.
• W2015296710 creator A5063763057 @default.
• W2015296710 creator A5088497242 @default.
• W2015296710 creator A5090478461 @default.
• W2015296710 date "2014-08-20" @default.
• W2015296710 modified "2023-09-26" @default.
• W2015296710 title "Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone" @default.
• W2015296710 cites W1493383013 @default.
• W2015296710 cites W1870319372 @default.
• W2015296710 cites W1979282061 @default.
• W2015296710 cites W1982075489 @default.
• W2015296710 cites W1992659422 @default.
• W2015296710 cites W1996804028 @default.
• W2015296710 cites W2013675509 @default.
• W2015296710 cites W2016290669 @default.
• W2015296710 cites W2044936430 @default.
• W2015296710 cites W2055021437 @default.
• W2015296710 cites W2056821819 @default.
• W2015296710 cites W2059572429 @default.
• W2015296710 cites W2061895294 @default.
• W2015296710 cites W2064201279 @default.
• W2015296710 cites W2074029198 @default.
• W2015296710 cites W2084688467 @default.
• W2015296710 cites W2099932522 @default.
• W2015296710 cites W2139995836 @default.
• W2015296710 cites W2142459943 @default.
• W2015296710 cites W2143051404 @default.
• W2015296710 cites W2156266538 @default.
• W2015296710 cites W2157594275 @default.
• W2015296710 cites W2158281754 @default.
• W2015296710 cites W2164341191 @default.
• W2015296710 cites W2167090973 @default.
• W2015296710 cites W2588804913 @default.
• W2015296710 cites W4238102997 @default.
• W2015296710 cites W4255758041 @default.
• W2015296710 doi "https://doi.org/10.1186/1472-684x-13-42" @default.
• W2015296710 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4145161" @default.
• W2015296710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25165428" @default.
• W2015296710 hasPublicationYear "2014" @default.
• W2015296710 type Work @default.
• W2015296710 sameAs 2015296710 @default.
• W2015296710 citedByCount "13" @default.
• W2015296710 countsByYear W20152967102015 @default.
• W2015296710 countsByYear W20152967102016 @default.
• W2015296710 countsByYear W20152967102017 @default.
• W2015296710 countsByYear W20152967102018 @default.
• W2015296710 countsByYear W20152967102019 @default.
• W2015296710 countsByYear W20152967102020 @default.
• W2015296710 countsByYear W20152967102021 @default.
• W2015296710 countsByYear W20152967102022 @default.
• W2015296710 crossrefType "journal-article" @default.
• W2015296710 hasAuthorship W2015296710A5010842306 @default.
• W2015296710 hasAuthorship W2015296710A5013858600 @default.
• W2015296710 hasAuthorship W2015296710A5018795520 @default.
• W2015296710 hasAuthorship W2015296710A5020320519 @default.
• W2015296710 hasAuthorship W2015296710A5030542961 @default.
• W2015296710 hasAuthorship W2015296710A5040190541 @default.
• W2015296710 hasAuthorship W2015296710A5063763057 @default.
• W2015296710 hasAuthorship W2015296710A5088497242 @default.
• W2015296710 hasAuthorship W2015296710A5090478461 @default.
• W2015296710 hasBestOaLocation W20152967101 @default.
• W2015296710 hasConcept C126322002 @default.
• W2015296710 hasConcept C170493617 @default.
• W2015296710 hasConcept C2775962371 @default.
• W2015296710 hasConcept C2776029756 @default.
• W2015296710 hasConcept C2778750930 @default.
• W2015296710 hasConcept C2779886867 @default.
• W2015296710 hasConcept C2781063702 @default.
• W2015296710 hasConcept C2781072394 @default.
• W2015296710 hasConcept C42219234 @default.
• W2015296710 hasConcept C71924100 @default.
• W2015296710 hasConcept C98274493 @default.
• W2015296710 hasConceptScore W2015296710C126322002 @default.
• W2015296710 hasConceptScore W2015296710C170493617 @default.
• W2015296710 hasConceptScore W2015296710C2775962371 @default.
• W2015296710 hasConceptScore W2015296710C2776029756 @default.
• W2015296710 hasConceptScore W2015296710C2778750930 @default.
• W2015296710 hasConceptScore W2015296710C2779886867 @default.
• W2015296710 hasConceptScore W2015296710C2781063702 @default.
• W2015296710 hasConceptScore W2015296710C2781072394 @default.
• W2015296710 hasConceptScore W2015296710C42219234 @default.
• W2015296710 hasConceptScore W2015296710C71924100 @default.
• W2015296710 hasConceptScore W2015296710C98274493 @default.
• W2015296710 hasIssue "1" @default.
• W2015296710 hasLocation W20152967101 @default.
• W2015296710 hasLocation W20152967102 @default.
• W2015296710 hasLocation W20152967103 @default.
• W2015296710 hasLocation W20152967104 @default.
• W2015296710 hasOpenAccess W2015296710 @default.
• W2015296710 hasPrimaryLocation W20152967101 @default.
• W2015296710 hasRelatedWork W1577133669 @default.
• W2015296710 hasRelatedWork W1985082623 @default.
• W2015296710 hasRelatedWork W1996174501 @default.

• next